E-LIB Suche - Ergebnisse für: Gambier, Hélène - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

Atlas sur les réalisations des programmes de développement ..:

Gambier, Hélène ; Gendre, Cedric ; Berriet-Solliec, Marielle...
hal-04186503. , 2023

Link: https://hal.inrae.fr/hal..

2

Atlas sur les réalisations des programmes de développement ..:

Gambier, Hélène ; Gendre, Cedric ; Berriet-Solliec, Marielle...
hal-04186503. , 2023

Link: https://hal.inrae.fr/hal..

3

Atlas sur les réalisations des programmes de développement ..:

Gambier, Hélène ; Gendre, Cedric ; Berriet-Solliec, Marielle...
hal-04186503. , 2023

Link: https://hal.inrae.fr/hal..

4

Acute Psychiatric Disorders Related to Fake Cathinone: Ephy..:

Serre, Anais ; Vuillot, Olivier ; Eiden, Céline...
Journal of Analytical Toxicology. 43 (2019) 7 - p. e1-e2 , 2019

Link: https://doi.org/10.1093/..

5

Annual report of the Board of Regents of the of the Smithso..

United States congressional serial set ; serial set no. 3341;Mis. doc. / 53rd Congress, 3rd session. House ; no. 90, pt. 1

Billings, John Shaw ; Binet, Alfred ; Bonfort, Helene... , 1895

Link: http://docs.newsbank.com..

6

Tocilizumab plus dexamethasone versus dexamethasone in pati..:

Hermine, Olivier ; Mariette, Xavier ; Porcher, Raphael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2022.101362. , 2022

Link: https://inserm.hal.scien..

7

Tocilizumab plus dexamethasone versus dexamethasone in pati..:

Hermine, Olivier ; Mariette, Xavier ; Porcher, Raphael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2022.101362. , 2022

Link: https://inserm.hal.scien..

8

Tocilizumab plus dexamethasone versus dexamethasone in pati..:

Hermine, Olivier ; Mariette, Xavier ; Porcher, Raphael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2022.101362. , 2022

Link: https://inserm.hal.scien..

9

Tocilizumab plus dexamethasone versus dexamethasone in pati..:

Hermine, Olivier ; Mariette, Xavier ; Porcher, Raphael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2022.101362. , 2022

Link: https://inserm.hal.scien..

10

Tocilizumab plus dexamethasone versus dexamethasone in pati..:

Hermine, Olivier ; Mariette, Xavier ; Porcher, Raphael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2022.101362. , 2022

Link: https://inserm.hal.scien..

11

Tocilizumab plus dexamethasone versus dexamethasone in pati..:

Hermine, Olivier ; Mariette, Xavier ; Porcher, Raphael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2022.101362. , 2022

Link: https://inserm.hal.scien..

12

Tocilizumab plus dexamethasone versus dexamethasone in pati..:

Hermine, Olivier ; Mariette, Xavier ; Porcher, Raphael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2022.101362. , 2022

Link: https://inserm.hal.scien..

13

Tocilizumab plus dexamethasone versus dexamethasone in pati..:

Hermine, Olivier ; Mariette, Xavier ; Porcher, Raphael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2022.101362. , 2022

Link: https://inserm.hal.scien..

14

Tocilizumab plus dexamethasone versus dexamethasone in pati..:

Hermine, Olivier ; Mariette, Xavier ; Porcher, Raphael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2022.101362. , 2022

Link: https://inserm.hal.scien..

15

Tocilizumab plus dexamethasone versus dexamethasone in pati..:

Hermine, Olivier ; Mariette, Xavier ; Porcher, Raphael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2022.101362. , 2022

Link: https://inserm.hal.scien..

1-15